Advanced Nuclear Medicine Ingredents
Develops radiometals labeled radiopharmaceuticals and a global service provider in the radiopharmaceutical field.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD9m (Public information from Nov 2018)
Company register number 0627.636.718
Liège Liège (HQ)
Authorizing premium user...